California Company Signs Stem Cell Deal with WI Foundation

MADISON, Wis. (AP) -- A California company hopes to use stem cell technology developed at the University of Wisconsin-Madison to make new medical and research products.

BioTime, Inc. has signed a licensing agreement with the Wisconsin Alumni Research Foundation to use 173 patents and patent applications covering human embryonic stem cell technology.

The patents cover some of the work of UW-Madison scientist James Thomson.

Embryonic stem cells can turn into any type of cell in the body, and BioTime plans to develop products that help scientists do that.

CEO Michael West says the cells could then be used in research for cures to disease and to develop new drugs.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

The comment sections of our web set are designed for thoughtful, intelligent conversation and debate. We want to hear from the viewers but we are not obligated to post comments we feel inappropriate or violate our guidelines. Here are some of the criteria you should follow when posting comments:

Comments cannot be profane or vulgar. Children and families visit this site. We will delete comments that use profanity or cross the lines of good taste.

We will delete all comments using hate speech. Slurs, stereotypes and violent talk aren’t welcome on our web site.

Comments should not attack other readers personally.

We will delete comments we deem offensive, in bad taste, or out of bounds. We are not obligated to post comments that are rude or insensitive.

We do not edit user-submitted comments.

As a host WEAU 13 News welcomes a wide spectrum of opinions. However, we have a responsibility to all our readers to try to keep our comment section fair and decent. For that reason WEAU 13 News reserves the right to not post or to remove any comment.
powered by Disqus